What is the investment case, and what must be true for it to hold?
Parakeet Health announced a $10 million Series A in October 2026 after reporting tenfold annual recurring revenue growth over the preceding year. Its announcement describes customers spanning six of the country's ten largest dermatology groups.
The company reported support for more than 2,800 providers across over 1,100 locations. It plans to expand its team, personalization capabilities, and specialty coverage, including primary care, behavioral health, women's health, eyecare, and radiology.
How does its pricing position it against rivals?
Parakeet Health uses a performance-based commercial model linked to verified outcomes. Its official announcement identifies booked appointments, resolved interactions, and generated revenue as examples of those outcomes.
The company works with healthcare leadership to model potential financial impact and establish an evaluation framework before deployment. Dedicated customer-success and engineering teams configure workflows, connecting pricing incentives with the operational results customers seek.
What does the product do for its buyer, and how is it delivered?
Parakeet Health's platform automates appointment scheduling, cancellation recovery, referral management, and after-hours access. Its conversational agents coordinate inbound and outbound patient interactions across voice, SMS, email, web, and fax.
The system connects to electronic health records and practice-management software. Rules account for provider preferences, visit types, insurance requirements, and location-specific workflows, with routine work automated and exceptions overseen by staff.

Parakeet Health develops conversational AI that automates patient access and scheduling for healthcare organizations.